Posters, Presentations & Publications
For Presentations and Posters in PDF Adobe Acrobat Reader is required. If you experience problems downloading the PDF, see Note in right margin, or we can send an 11x17 hard copy to you. Please e-mail info@inspirepharm.com with name, address, &  telephone number.

2008  2007  2006  2005  2004  2003  2002  2001  2000  1996-1999

Novack GD, Evans R. Commercially available ocular hypotensive products: preservative concentration, stability, storage and in-life utilization. J Glaucoma, 2001 Dec, 10:483-486.

Yerxa B, Zhang L, Sheridan C, Peterson W, Cowlen M. Cellular expression of P2Y2 receptor mRNA as visualized by in situ hybridization in rabbit and monkey eyes. Poster presented at the European Association for Vision and Eye Research. 2001 October 10-13; Alicante, Spain.

Jablons DM, Everett D, David G, Michels RY, Klein MG, Edgar P, Johnson FL. A single inhaled dose of INS316 (uridine 5'-triphosphate, UTP) enhances sputum quality for the diagnosis of lung cancer. Poster presented at the 11th Annual Meeting of the European Respiratory Society. 2001 September 22-26; Berlin, Germany.

Shaver SR. P2Y receptors: Biological advances and therapeutic opportunities. Curr Opin Drug Discov Devel, 2001 Sep, 4(5):665-670.

Noone PG, Hamblett N, Accurso F, Aitken ML, Boyle M, Dovey M, Gibson R, Johnson C, Kellerman D, Konstan MW, Milgram L, Mundahl J, Retsch-Bogort G, Rodman D, Williams-Warren J, Wilmott RW, Zeitlin P, Ramsey B. Safety of aerosolized INS365 in patients with mild to moderate cystic fibrosis: results of a phase I multi-center study. Pediatr Pulmonol 2001 Aug; 32(2):122-128.

Bennett WD, Zeman KL, Foy C, Shaffer CL, Johnson FL, Regnis JA, Sannuti A, Johnson J. Effect of aerosolized uridine 5'-triphosphate on mucociliary clearance in mild chronic bronchitis. Am J Respir Crit Care Med, 2001 Jul 15;164(2):302-306.

Mathews D, Kellerman D, Gorden J, Johnson C, Evans R. INS37217, a novel P2Y2 receptor agonist, being developed for the treatment of cystic fibrosis: results from initial phase 1 study in normal volunteers. Poster presented at the 24th European Cystic Fibrosis Conference. 2001 June 6-9; Vienna, Austria.

Foulks G, Sall K, Greenberg M, Tauber J, Donshik P, Berdy G, Sylvester R, Yerxa B, Crockett S, Kellerman D. Phase 2 dose ranging efficacy trial of INS365 ophthalmic solution, a P2Y2 agonist, in patients with dry eye. Powerpoint presentation by Gary Foulks, MD at the The Association for Research in Vision and Ophthalmology (ARVO) 2001 Annual Meeting. 2001 April 29 - May 4; Fort Lauderdale, Florida, USA.

Yerxa BR, Gukasyan HJ, Pendergast W, Lee VHL. Ecto-metabolism & transport efficiency of P2Y receptor agonists by rabbit ocular surface epithelial cells. Poster presented at The Association for Research in Vision and Ophthalmology (ARVO) 2001 Annual Meeting. 2001 April 29 - May 4; Fort Lauderdale, Florida, USA.

Peterson WM, Venturini AE, Cowlen MS, Vezina M, Piccirilli G. Metabolism, ocular distribution, and ERG effects of INS37217, a novel P2Y2 receptor agonist, for the treatment of retinal detachment. Poster presented at The Association for Research in Vision and Ophthalmology (ARVO) 2001 Annual Meeting. 2001 April 29 - May 4; Fort Lauderdale, Florida, USA.

Pintor J, Peral A, Hoyle C, Redick C, Douglass J, Sims I, Yerxa B. Effects of diadenosine polyphosphates on tear secretion in New Zealand white rabbits. Poster presented at The Association for Research in Vision and Ophthalmology (ARVO) 2001 Annual Meeting. 2001 April 29 - May 4; Fort Lauderdale, Florida, USA.

Meyer CH, Hotta K, Peterson WM, Toth CA, Jaffe GJ. The effects of INS37217, a P2Y2 receptor agonist, on the reabsorption rates of subretinal fluid in a rabbit model of retinal detachment. Poster presented at The Association for Research in Vision and Ophthalmology (ARVO) 2001 Annual Meeting. 2001 April 29 - May 4; Fort Lauderdale, Florida, USA.

Li Y, Yiming M, Yerxa B, Kuang K, Fischbarg J. Effects of ouabain and quinidine on fluid movements across rabbit conjunctival epithelium. Poster presented at The Association for Research in Vision and Ophthalmology (ARVO) 2001 Annual Meeting. 2001 April 29 - May 4; Fort Lauderdale, Florida, USA.

Mundasad MV, Novack GD, Allgood VE, Evans RM, Gorden JC, Yerxa BR. Ocular safety of INS365 ophthalmic solution: A P2Y2 agonist, in healthy subjects. J Ocular Pharmacol Ther, 2001 Apr, 17(2):173-179.

Kellerman DJ, Bennett WD, Zeman KL, Foy C, Gorden JC, Shaffer CL, Johnson FL. Dose response relationship of the P2Y2 agonist INS365 on mucociliary clearance in smokers. Poster presented at the American Academy of Allergy, Asthma and Immunology 57th Annual Meeting. 2001 March 16-21; New Orleans, Louisiana, USA.

Evans R, Kaufman B, Kellerman D, Boyd B, Farr S, Taylor G, Warren S. Characterization of the in-vitro and in-vivo performance of two popular air-jet nebulizers. Poster presented at the American Academy of Allergy, Asthma and Immunology 57th Annual Meeting. 2001 March 16-21; New Orleans, Louisiana, USA.

Pendergast W, Yerxa BR, Douglass JG 3rd, Shaver SR, Dougherty RW, Redick CC, Sims IF, Rideout JL. Synthesis and P2Y receptor activity of a series of uridine dinucleoside 5'-polyphosphates. Bioorg Med Chem Lett, 2001 Jan 22, 11(2):157-160.

Yerxa BR. Therapeutic use of nucleotides in respiratory and ophthalmic diseases. Drug Devel Res, 2001, 52:196-201.

 

Page last updated: 23-Jun-2008
Copyright © 1999-2005 Inspire Pharmaceuticals Inc. All rights reserved






 

 

Note: If you are having problems opening any of the Posters or Presentations in PDF, please refresh your page to clear out the attempt and then, with your mouse hovering over the link to the PDF document, right click and choose Save Target As, choose a location on your hard drive to save the document and click save. Once the download is complete you will be given a choice to Open, Open Folder or Close. Click Open and the PDF should open immediately. If you continue to have problems, please conact info@inspirepharm.com.